Varenicline
Back to searchMolecule Structure
Scientific Name
Varenicline
Description of the Drug
Varenicline is a partial agonist at nicotinic acetylcholine receptors used as an aid in smoking cessation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01273
http://www.drugbank.ca/drugs/DB01273
Brand Name(s)
Not Available
Company Owner(s)
Pf Prism Cv, Oyster Point Pharma Inc, Par Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Neuronal acetylcholine receptor; alpha4/beta2 | PROTEIN COMPLEX | PARTIAL AGONIST | CHEMBL1907589 |
| Neuronal acetylcholine receptor; alpha4/beta2 | PROTEIN COMPLEX | AGONIST | CHEMBL1907589 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL225687 | ||
| DrugBank | DB01273 | ||
| PubChem: Thomson Pharma | 15121200 | ||
| PubChem | 170361 | ||
| Mcule | MCULE-3341459784 | ||
| LINCS | LSM-45774 | ||
| Nikkaji | J2.566.151F | ||
| BindingDB | 50166908 | ||
| rxnorm | CHANTIX | VARENICLINE TARTRATE | VARENICLINE |
